Compare Johnson & Johnson (JNJ) vs Mattel Inc (MAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Mattel Inc — how do they compare? Johnson & Johnson trades at $260.83 (market cap $626.09B), while Mattel Inc trades at $14.74 (market cap $4.30B). The key difference: Johnson & Johnson is far larger — about 145.6× Mattel Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Mattel Inc pays none. Which is the better fit depends on your goals.
| JNJ | MAT | |
|---|---|---|
Market Cap | $626.09B | $4.30B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $22.16 |
52-Week Low | $172.78 | $13.05 |
Enterprise Value | $654.37B | $6.52B |
Dividend Yield | 2.06% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.
Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.
Mattel (MAT) trades at $15.03, up 1.97% today, with a bullish technical signal from moving averages. The company reported mixed Q2 2026 results, with a 10% revenue beat but an earnings miss due to higher costs. Valuation ratios appear reasonable with a P/E of 11.22 and P/S of 0.84. Analyst consensus is a 'Hold' with a $14.00 price target, slightly below the current price. Recent news highlights growth from toy-based movies and adult collectors, though profit margins face pressure from advertising and SG&A expenses.
The outlook for Mattel is cautiously optimistic, driven by IP expansion and brand strength, but near-term risks include cost inflation and discretionary spending headwinds. Investment opportunity lies in execution of entertainment strategy, while key risks are margin compression and competitive pressures. The stock's current level near analyst targets suggests limited upside without improved earnings momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Mattel Inc
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →
